Hypermethylation of the APC promoter but lack of APC mutations in myxoid/round-cell liposarcoma

International Journal of Cancer

Volumn 119, Issue 10, 2006, Pages 2347-2352

  Sievers, Sonja ^a,b   Fritzsch, Carla ^a   Lehnhardt, Marcus ^b   Zahn, Susanne ^c   Kutzner, Nadine ^a   Kuhnen, Cornelius ^b   Müller, Oliver ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Adenomatous polyposis coli; Liposarcoma; Methylation

Indexed keywords

APC PROTEIN; BETA CATENIN; ONCOPROTEIN; WNT PROTEIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE CLUSTER; GENE CONTROL; GENE INACTIVATION; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MYXOSARCOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN STABILITY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOFT TISSUE SARCOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BETA CATENIN; DNA METHYLATION; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIGENESIS, GENETIC; FEMALE; GENE SILENCING; GENES, APC; HUMANS; LIPOSARCOMA, MYXOID; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 33749588194     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22117     Document Type: Article

References (33)

1. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-9.
2. Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol 2003;4:351-8.
3. Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M, Kurdistani SK. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005;435:1262-6.
4. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003;1653:1-24.
5. Mentzel T, Fletcher CD. Lipomatous tumours of soft tissues: an update. Virchows Arch 1995;427:353-63.
6. Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma. Cancer Genet Cytogenet 2004;155:1-24.
7. Kilpatrick SE, Doyon J, Choong PF, Sim FH, Nascimento AG. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer 1996;77:1450-8.
8. Perez-Losada J, Pintado B, Gutierrez-Adan A, Flores T, Banares-Gonzalez B, del Campo JC, Martin-Martin JF, Battaner E, Sanchez-Garcia I. The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene 2000;19:2413-22.
9. Adelmant G, Gilbert JD, Freytag SO. Human translocation liposarcoma-CCAAT/enhancer binding protein (C/EBP) homologous protein (TLS-CHOP) oncoprotein prevents adipocyte differentiation by directly interfering with C/EBPβ function. J Biol Chem 1998;273:15574-81.
10. Kuhnen C, Herter P, Muller O, Muehlberger T, Krause L, Homann H, Steinau HU, Muller KM. β-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas. Mod Pathol 2000;13:1005-13.
11. Wada M, Miller CW, Yokota J, Lee E, Mizoguchi H, Koeffler HP. Molecular analysis of the adenomatous polyposis coli gene in sarcomas, hematological malignancies and noncolonic, neoplastic tissues. J Mol Med 1997;75:139-44.
12. Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ. Increased β-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 1997;151:329-34.
13. Saito T, Oda Y, Sakamoto A, Kawaguchi K, Tanaka K, Matsuda S, Tamiya S, Iwamoto Y, Tsuneyoshi M. APC mutations in synovial sarcoma. J Pathol 2002;196:445-9.
14. Weiss SW, Goldblum JR. Liposarcoma. In: Enzinger FM, Weiss SW, eds. Soft tissue tumours. Philadelphia: Mosby Harcourt, 2001. 641-93.
15. Grunau C, Clark SJ, Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 2001;29:E65.
16. Santoro IM, Groden J. Alternative splicing of the APC gene and its association with terminal differentiation. Cancer Res 1997;57:488-94.
17. Lin P, Hu SW, Chang TH. Correlation between gene expression of aryl hydrocarbon receptor (AhR), hydrocarbon receptor nuclear translocator (Arm), cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and inducibility of CYP1A1 and CYP1B1 in human lymphocytes. Toxicol Sci 2003;71:20-6.
18. Kahmann S, Herter P, Kuhnen C, Muller KM, Muhr G, Martin D, Soddemann M, Muller O. A non-radioactive protein truncation test for the sensitive detection of all stop and frameshift mutations. Hum Mutat 2002;19:165-72.
19. Sievers et al. Biomarkers 2006;11:270-8.
20. Tickenbrock L, Kossmeier K, Rehmann H, Hermann C, Muller O. Differences between the interaction of β-catenin with non-phosphorylated and single-mimicked phosphorylated 20-amino acid residue repeats of the APC protein. J Mol Biol 2003;327:359-67.
21. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, Aoki T, Miki Y, Mori T, Nakamura Y. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1992;1:229-33.
22. Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Ando H, Yanagisawa A, Tsuchiya E, Kato Y, Nakamura Y. Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res 1992; 52:6696-8.
23. Nakatsuru S, Yanagisawa A, Ichii S, Tahara E, Kato Y, Nakamura Y, Horii A. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet 1992;1:559-63.
24. Furuuchi K, Tada M, Yamada H, Kataoka A, Furuuchi N, Hamada J, Takahashi M, Todo S, Moriuchi T. Somatic mutations of the APC gene in primary breast cancers. Am J Pathol 2000;156:1997-2005.
25. Takahira T, Oda Y, Tamiya S, Yamamoto H, Kawaguchi K, Kobayashi C, Iwamoto Y, Tsuneyoshi M. Alterations of the p16INK4a/p14ARF pathway in clear cell sarcoma. Cancer Sci 2004;95:651-5.
26. Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer SJ, Baylin SB, Herman JG. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 2000;60:4366-71.
27. Sarrio D, Moreno-Bueno G, Hardisson D, Sanchez-Estevez C, Guo M, Herman JG, Gamallo C, Esteller M, Palacios J. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 2003;106:208-15.
28. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-7.
29. Usadel H, Bratender J, Danenterg KD, Jeronimo C, Harden S, Engles J, Danenberg PV, Yang S, Sidransky D. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002;62:371-5.
30. Florl AR, Steinhoff C, Muller M, Seifert HH, Hader C, Engers R, Ackermann R, Schulz WA. Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation. Br J Cancer 2004;91:985-94.
31. Jin Z, Tamura G, Tsuchiya T, Sakata K, Kashiwaba M, Osakabe M, Motoyama T. Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br J Cancer 2001;85:69-73.
32. Nathke IS. The adenomatous polyposis coli protein: the achilles heel of the gut epithelium. Annu Rev Cell Dev Biol 2004;20:337-66.
33. Tamura G. Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia. Histol Histopathol 2004;19:221-8.